SEC Form 4 · accession 0000939767-18-000031

EXELIXIS, INC. · EXEL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Sr. Vice President, Commercial

Period of report

Feb 28, 2018

Accepted (ET)

Mar 2, 2018 · 8:00 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000939767

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Feb 28, 2018	M	10,625	$1.76	A	155,519	D
Common Stock	Feb 28, 2018	M	3,000	$5.50	A	158,519	D
Common Stock^F2	Feb 28, 2018	S	45,029	$27.13	D	113,490	D
Common Stock	holding	—	—		—	23,539	I	By spouse
Common Stock^F3	holding	—	—		—	10,101	I	By 401(k)

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F4	$1.76	Feb 28, 2018	M	10,625	D	Nov 17, 2015	Nov 16, 2021	Common Stock	10,625	39,375	D
Option (right to buy)^F5	$5.50	Feb 28, 2018	M	3,000	D	Sep 28, 2012	Sep 27, 2018	Common Stock	3,000	0	D

F1Includes 67,602 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $27.03 to $27.25. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 28, 2018.
F4The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, was exercisable as to 40,625 shares as of the Transaction Date. The remainder of the option will vest as to 1/48th of the original number of shares subject to the option on each monthly anniversary of November 17, 2014 grant date.
F5The option, representing the right to purchase a total of 3,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015.